Schroder Investment Management Group
AMPH icon

Schroder Investment Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Schroder Investment Management Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-44,326
Closed -$1.24M – 1255
2022
Q4 		$1.24M Sell
44,326
-14,850
-25% -$431K ﹤0.01% 1024
2022
Q3 		$1.66M Sell
59,176
-456
-0.8% -$14.9K ﹤0.01% 972
2022
Q2 		$2.04M Buy
+59,632
New +$2.13M ﹤0.01% 960

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Schroder Investment Management Group's AMPH Position: Q1 2023 in Review

Schroder Investment Management Group sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 44,326 shares — an estimated $1.24M sold.

Schroder Investment Management Group first reported a position in AMPH in Q2 2022 and held it in 3 quarters. The position peaked at $2.04M in Q2 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

  • Schroder Investment Management Group reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 44,326 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $1.24M.
  • Schroder Investment Management Group first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Schroder Investment Management Group's Amphastar Pharmaceuticals position peaked at $2.04M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.